Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: Effect of TTNS and PNS on Neurogenic Overactive Bladder Symptoms in Female Patients With Multiple Sclerosis. [NA]
A completed clinical trial evaluating transcutaneous tibial nerve stimulation (TTNS) and peripheral nerve stimulation (PNS) for neurogenic o…
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: Repetitive Transcranial Magnetic Stimulation (rTMS) in MS Induced Spastic Paraparesis [NA]
A clinical trial is actively recruiting to evaluate repetitive transcranial magnetic stimulation for spastic paraparesis in people with mult…
-
CLINICAL_TRIALS withdrawal · 2025-12-04Clinical Trial Update: Managed Access Program (MAP) for Patients Diagnosed With Secondary Progressive Multiple Sclerosis With Active Disease
The clinical trial update confirms that the Novartis-sponsored Managed Access Program for patients with secondary progressive multiple scler…
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: Libyan Multiple Sclerosis Registry Study
The Libyan Multiple Sclerosis Registry study (NCT07264725) conducted by the University of Zintan is marked as completed.
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: A Multicenter Clinical Trial Evaluating the Efficacy and Safety of Taurine as an Adjunctive Therapy in Multiple Sclerosis [Phase 2]
A Phase 2 multicenter trial is evaluating taurine as an adjunctive therapy for relapsing-remitting multiple sclerosis; the study is not yet …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: A Study to Investigate Arbaclofen ER Tablets for the Treatment of Spasticity in Patients With Multiple Sclerosis [Phase 3]
A Phase 3 clinical trial update for Arbaclofen ER tablets in the treatment of spasticity in patients with multiple sclerosis; the study is c…
-
CLINICAL_TRIALS trial_result · 2025-12-03Clinical Trial Update: Clinical Monitoring, MRI and Neuro-Ophthalmology of a Cohort of Patients With a Clinically Isolated Syndrome (CIS)
This completed clinical trial update describes monitoring, MRI and neuro-ophthalmology assessments in a cohort of patients with Clinically I…
-
CLINICAL_TRIALS trial_result · 2025-12-03Clinical Trial Update: Upper Limb Muscle Strength Models for Patients With Motor Impairment. [NA]
A completed clinical trial investigating upper limb muscle strength models for patients with motor impairment due to stroke, multiple sclero…
-
CLINICAL_TRIALS withdrawal · 2025-12-02Clinical Trial Update: A Lactation Study in Women Receiving Treatment With Ozanimod [Phase 4]
A Phase 4 lactation study of ozanimod (Zeposia) in women receiving treatment has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2025-12-02Clinical Trial Update: Rehabilitation Protocol for Disorders on Hand Sensitivity in Multiple Sclerosis Patients. [NA]
A clinical trial evaluating a rehabilitation protocol for hand sensitivity issues in multiple sclerosis patients has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-12-02Clinical Trial Update: Deficit-specific Training in Spinal Disorders [NA]
The University of Zurich study on deficit-specific rehabilitation training for spinal cord injuries and multiple sclerosis has completed; no…
-
CLINICAL_TRIALS trial_result · 2025-12-01Clinical Trial Update: Prognostic Value of Three New Biomarkers of Multiple Sclerosis in Patients With Radiologically Isolated Syndrome
This clinical trial update evaluates whether three novel biomarkers have prognostic value for progression from radiologically isolated syndr…
-
CLINICAL_TRIALS research · 2025-12-01Clinical Trial Update: Comprehensive Therapeutic Program For People With Multiple Sclerosis [NA]
This clinical trial update outlines a comprehensive therapeutic program for people with multiple sclerosis with a focus on neurorehabilitati…
-
CLINICAL_TRIALS research · 2025-12-01Clinical Trial Update: Hypnosis and Attention in Patients With a Neurological Disease (Stroke, Traumatic Brain Injury and Multiple Sclerosis) [NA]
A clinical trial is investigating hypnosis and attention in patients with stroke, traumatic brain injury, and multiple sclerosis and is curr…
-
CLINICAL_TRIALS trial_result · 2025-12-01Clinical Trial Update: Personalized Nutrition Advice for Optimizing Dietary Calcium Intake in MS Patients [NA]
This ClinicalTrials.gov entry reports a completed study investigating personalized nutrition advice to optimize dietary calcium intake in pe…
-
CLINICAL_TRIALS trial_result · 2025-12-01Clinical Trial Update: Environmental Risk Factors in Multiple Sclerosis Development: Epidemiological Study of EBV Infection and Vitamin D Deficiency in RIS Patients
This completed clinical trial investigates environmental risk factors for developing multiple sclerosis in radiologically isolated syndrome …
-
EMA approval · 2025-11-28EMA Authorised: Fingolimod Mylan (Fingolimod) — Mylan Pharmaceuticals Limited
The European Medicines Agency authorised Fingolimod Mylan, a generic version of fingolimod, for relapsing-remitting multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2025-11-28Clinical Trial Update: Observational Study of the Effect of Ozanimod on Fatigue in Multiple Sclerosis Patients
An observational study evaluating the effect of ozanimod on fatigue in patients with multiple sclerosis has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-11-26Clinical Trial Update: Prospective Case Series to Refine Standalone Cognitive Behavioral Therapy Components for Multiple Sclerosis Fatigue [NA]
A completed prospective case series assessing standalone cognitive behavioral therapy components for fatigue in people with multiple scleros…
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: Immune System Effects in Children Born to Women With Multiple Sclerosis Treated With Monoclonal Antibody Therapy During Pregnancy
A clinical trial protocol assessing immune-system effects in children born to women with multiple sclerosis who were treated with monoclonal…
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: Study of Ovarian Reserve Concerning Patients With Multiple Sclerosis (MS), Compared to a Control Group [NA]
This clinical trial update describes a study comparing ovarian reserve in patients with Multiple Sclerosis to a control group, currently rec…
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: Investigating the Effects of Wearable Robotic Exoskeleton for Improving Mobility and Cognition in Persons With MS [NA]
Clinical trial update on a wearable robotic exoskeleton study aimed at improving mobility and cognition in individuals with multiple scleros…
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: Evaluation of the Clinical Contribution of Quantitative MRI in Neuro-imaging [NA]
A clinical trial update evaluating the contribution of quantitative MRI in neuro-imaging for Multiple Sclerosis; the study is not yet recrui…
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease
A ClinicalTrials.gov update describes a biospecimen collection study led by TScan Therapeutics to identify targets of disease-reactive T cel…
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: Ocrelizumab Access by Socio-Economic Status
The report summarizes a completed clinical trial assessing access to ocrelizumab for multiple sclerosis patients across socio-economic group…